Australia TGA Suspends Corpuls Defibrillators: What It Means for Post-Market Compliance

Medical Device Global Market Access · Aug 17, 2026 · 5m

On August 12, 2026, Australia's Therapeutic Goods Administration (TGA) suspended the supply of Corpuls 3 and 3T defibrillators. This episode breaks down the TGA's precautionary action, clarifying the critical difference between a supply suspension and a device recall. We explore why the TGA acted, who is affected, and what this signals about the regulator's increasingly proactive approach to post-market surveillance. Learn the practical steps all medical device manufacturers should take to ensure their ongoing compliance in the Australian market. Key Questions: - What did Australia's TGA…